Literature DB >> 11122566

Helsinki discord? A controversial declaration.

B Vastag.   

Abstract

Keywords:  Biomedical and Behavioral Research; World Medical Association

Mesh：

Substances：

Year:  2000        PMID： 11122566     DOI： 10.1001/jama.284.23.2983

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  The necessity and the value of placebo.

Authors:  Ernst A Singer
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

2.  Primary chemotherapy-associated effect of second-line chemotherapy on survival of patients with advanced ovarian cancer.

Authors:  Seiji Isonishi; Masanori Hirama; Motoaki Saitou; Makoto Yasuda; Tadao Tanaka
Journal:  Int J Clin Oncol       Date:  2006-06       Impact factor: 3.402

Review 3.  Key concepts of clinical trials: a narrative review.

Authors:  Craig A Umscheid; David J Margolis; Craig E Grossman
Journal:  Postgrad Med       Date:  2011-09       Impact factor: 3.840

4.  Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group.

Authors:  A Buda; I Floriani; R Rossi; N Colombo; V Torri; P F Conte; R Fossati; A Ravaioli; C Mangioni
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.